Suppr超能文献

阿尔茨海默病与轻度认知障碍。

Alzheimer's disease and mild cognitive impairment.

作者信息

Kelley Brendan J, Petersen Ronald C

机构信息

Mayo Clinic, Department of Neurology, Rochester, MN 55905, USA.

出版信息

Neurol Clin. 2007 Aug;25(3):577-609, v. doi: 10.1016/j.ncl.2007.03.008.

Abstract

As our society ages, age-related diseases assume increasing prominence as both personal and public health concerns. Disorders of cognition are particularly important in both regards, and Alzheimer's disease is by far the most common cause of dementia of aging. In 2000, the prevalence of Alzheimer's disease in the United States was estimated to be 4.5 million individuals, and this number has been projected to increase to 14 million by 2050. Although not an inevitable consequence of aging, these numbers speak to the dramatic scope of its impact. This article focuses on Alzheimer's disease and the milder degrees of cognitive impairment that may precede the clinical diagnosis of probable Alzheimer's disease, such as mild cognitive impairment.

摘要

随着我们的社会老龄化,与年龄相关的疾病作为个人和公共健康问题日益突出。认知障碍在这两方面都尤为重要,而阿尔茨海默病是迄今为止导致老年痴呆症最常见的原因。2000年,美国阿尔茨海默病的患病率估计为450万人,预计到2050年这一数字将增至1400万。尽管这并非衰老的必然结果,但这些数字表明了其影响的巨大范围。本文重点关注阿尔茨海默病以及在可能的阿尔茨海默病临床诊断之前可能出现的较轻程度的认知障碍,如轻度认知障碍。

相似文献

1
Alzheimer's disease and mild cognitive impairment.
Neurol Clin. 2007 Aug;25(3):577-609, v. doi: 10.1016/j.ncl.2007.03.008.
4
Motor function in subjects with mild cognitive impairment and early Alzheimer's disease.
Dement Geriatr Cogn Disord. 2005;19(5-6):299-304. doi: 10.1159/000084555. Epub 2005 Mar 22.
5
Mild cognitive impairment in older people.
Lancet. 2002 Dec 14;360(9349):1963-5. doi: 10.1016/S0140-6736(02)11920-9.
6
Mild cognitive impairment: a nosological entity?
Curr Opin Neurol. 2003 Dec;16 Suppl 2:S43-5.
7
Using magnetoencephalography to study patterns of brain magnetic activity in Alzheimer's disease.
Am J Alzheimers Dis Other Demen. 2006;21(6):416-23. doi: 10.1177/1533317506293502.
8
Impaired verb fluency: a sign of mild cognitive impairment.
Brain Lang. 2005 Nov;95(2):273-9. doi: 10.1016/j.bandl.2005.01.010.
9
A clinical index to predict progression from mild cognitive impairment to dementia due to Alzheimer's disease.
PLoS One. 2014 Dec 8;9(12):e113535. doi: 10.1371/journal.pone.0113535. eCollection 2014.

引用本文的文献

3
An Update on Neuroaging on Earth and in Spaceflight.
Int J Mol Sci. 2025 Feb 18;26(4):1738. doi: 10.3390/ijms26041738.
4
Correlation of muscle strength, information processing speed and cognitive function in the elderly with cognitive impairment--evidence from EEG.
Front Aging Neurosci. 2025 Jan 20;17:1496725. doi: 10.3389/fnagi.2025.1496725. eCollection 2025.
6
Glymphatic system clearance and Alzheimer's disease risk: a CSF proteome-wide study.
Alzheimers Res Ther. 2025 Jan 31;17(1):31. doi: 10.1186/s13195-024-01612-7.
7
The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases.
Brain Behav Immun Health. 2024 Dec 24;43:100932. doi: 10.1016/j.bbih.2024.100932. eCollection 2025 Feb.
9
Linking the neural signature of response time variability to Alzheimer's disease pathology and cognitive functioning.
Netw Neurosci. 2024 Oct 1;8(3):697-713. doi: 10.1162/netn_a_00373. eCollection 2024.
10
The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis.
Front Nutr. 2024 Jul 12;11:1424972. doi: 10.3389/fnut.2024.1424972. eCollection 2024.

本文引用的文献

1
PET of brain amyloid and tau in mild cognitive impairment.
N Engl J Med. 2006 Dec 21;355(25):2652-63. doi: 10.1056/NEJMoa054625.
2
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment.
J Neurol Sci. 2006 Dec 21;251(1-2):124-8. doi: 10.1016/j.jns.2006.09.014. Epub 2006 Nov 9.
3
Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup.
Top Magn Reson Imaging. 2005 Dec;16(6):427-37. doi: 10.1097/01.rmr.0000245463.36148.12.
4
Amyloid imaging of Alzheimer's disease using Pittsburgh Compound B.
Curr Neurol Neurosci Rep. 2006 Nov;6(6):496-503. doi: 10.1007/s11910-006-0052-5.
5
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
N Engl J Med. 2006 Oct 12;355(15):1525-38. doi: 10.1056/NEJMoa061240.
6
Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway.
Brain. 2006 Nov;129(Pt 11):2823-39. doi: 10.1093/brain/awl251. Epub 2006 Sep 29.
7
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Brain. 2006 Nov;129(Pt 11):3035-41. doi: 10.1093/brain/awl269. Epub 2006 Sep 29.
8
Quantitative MR imaging in Alzheimer disease.
Radiology. 2006 Oct;241(1):26-44. doi: 10.1148/radiol.2411050628.
9
Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42.
Neurology. 2006 Sep 12;67(5):830-3. doi: 10.1212/01.wnl.0000234030.77831.5a.
10
Postmenopausal estrogen therapy and Alzheimer disease: overall negative findings.
Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3):141-6. doi: 10.1097/00002093-200607000-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验